JP2024522163A5 - - Google Patents
Info
- Publication number
- JP2024522163A5 JP2024522163A5 JP2023575488A JP2023575488A JP2024522163A5 JP 2024522163 A5 JP2024522163 A5 JP 2024522163A5 JP 2023575488 A JP2023575488 A JP 2023575488A JP 2023575488 A JP2023575488 A JP 2023575488A JP 2024522163 A5 JP2024522163 A5 JP 2024522163A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- disease
- activator
- disorder
- subject requiring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208150P | 2021-06-08 | 2021-06-08 | |
| US63/208,150 | 2021-06-08 | ||
| PCT/US2022/032674 WO2022261207A1 (en) | 2021-06-08 | 2022-06-08 | Novel particle composition comprising sialic acid binding ligand |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522163A JP2024522163A (ja) | 2024-06-11 |
| JP2024522163A5 true JP2024522163A5 (enExample) | 2025-06-17 |
Family
ID=84426331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575488A Pending JP2024522163A (ja) | 2021-06-08 | 2022-06-08 | シアル酸結合リガンドを含む新規の粒子組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240358653A1 (enExample) |
| EP (1) | EP4351520A4 (enExample) |
| JP (1) | JP2024522163A (enExample) |
| CN (1) | CN117750946A (enExample) |
| AU (1) | AU2022289003A1 (enExample) |
| CA (1) | CA3221371A1 (enExample) |
| WO (1) | WO2022261207A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118178673B (zh) * | 2024-04-07 | 2024-11-05 | 铭畅生物医药南通有限公司 | 一种唾液酸酯环糊精包合物及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100196280A1 (en) * | 2006-06-08 | 2010-08-05 | Katrin Claudia Fischer | Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications |
| WO2008039920A2 (en) * | 2006-09-27 | 2008-04-03 | Board Of Regents, The University Of Texas System | Temperature-sensitive nanoparticles for controlled drug delivery |
| US20100009007A1 (en) * | 2008-07-10 | 2010-01-14 | Baxter International Inc. | Non-covalent modification of microparticles and process of preparing same |
| EP2366386A4 (en) * | 2008-10-28 | 2013-11-27 | Univ Santiago Compostela | NANOTEHTIC SYSTEMS MANUFACTURED FROM ANIONIC POLYMERS |
| GB0922066D0 (en) * | 2009-12-17 | 2010-02-03 | Univ Belfast | Modulator |
| US9241913B2 (en) * | 2011-05-19 | 2016-01-26 | Syracuse University | Polysialic acid-based N-trimethyl chitosan gel nanoparticles for systemic drug delivery |
| ES2711669A1 (es) * | 2017-11-02 | 2019-05-06 | Univ Santiago Compostela | Sistemas de liberacion de farmacos de acido polisialico y metodos |
| AU2020283956A1 (en) * | 2019-05-28 | 2021-12-16 | Cytodigm, Inc. | Microparticles and nanoparticles having sulfate groups on the surface |
-
2022
- 2022-06-08 EP EP22820961.5A patent/EP4351520A4/en active Pending
- 2022-06-08 JP JP2023575488A patent/JP2024522163A/ja active Pending
- 2022-06-08 WO PCT/US2022/032674 patent/WO2022261207A1/en not_active Ceased
- 2022-06-08 AU AU2022289003A patent/AU2022289003A1/en not_active Abandoned
- 2022-06-08 CA CA3221371A patent/CA3221371A1/en active Pending
- 2022-06-08 CN CN202280050112.0A patent/CN117750946A/zh active Pending
-
2023
- 2023-12-08 US US18/533,351 patent/US20240358653A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541432A5 (enExample) | ||
| JP2023041862A5 (enExample) | ||
| JP2022009090A5 (enExample) | ||
| JP2020033360A5 (enExample) | ||
| JP2023519965A5 (enExample) | ||
| JP2020509024A5 (enExample) | ||
| JP2020117553A5 (enExample) | ||
| JP2002508397A5 (enExample) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2017506624A5 (enExample) | ||
| JP2018507243A5 (enExample) | ||
| JP2023535744A5 (enExample) | ||
| IL320452A (en) | Combination therapy for prostate cancer | |
| JP2025509510A5 (enExample) | ||
| JP2024530189A5 (enExample) | ||
| Librodo et al. | Chronotherapeutic drug delivery | |
| JP2021509395A5 (enExample) | ||
| JP2024517085A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2021505669A5 (enExample) | ||
| CN105682671A (zh) | 用于管理癌症和治疗癌症并存病的方法 | |
| JP2025511402A5 (enExample) | ||
| JP2019535830A5 (enExample) | ||
| JP2023539154A5 (enExample) | ||
| JP2024531799A5 (enExample) |